Monitoring cartilage turnover (Q36793231)

16 August 2017

1 reference

title

Monitoring cartilage turnover (English)

1 reference

16 August 2017

1 reference

Nadine Charni-Ben Tabassi

series ordinal

1

1 reference

PubMed ID

17437662

16 August 2017

Patrick Garnero

series ordinal

2

1 reference

16 August 2017

1 April 2007

1 reference

Current Rheumatology Reports

16 August 2017

1 reference

16 August 2017

9

1 reference

16 August 2017

1

1 reference

16 August 2017

16-24

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-007-0017-y

16 August 2017

0 references

cites work

Fibronectin fragments in osteoarthritic synovial fluid

1 reference

12 December 2020

Classification of osteoarthritis biomarkers: a proposed approach.

1 reference

12 December 2020

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases

1 reference

12 December 2020

Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study

1 reference

12 December 2020

Structure and function of aggrecan

1 reference

12 December 2020

Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing i

1 reference

12 December 2020

Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments

1 reference

12 December 2020

Evidence for altered synthesis of type II collagen in patients with osteoarthritis

1 reference

12 December 2020

A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway

1 reference

12 December 2020

Identification of fibronectin neoepitopes present in human osteoarthritic cartilage

1 reference

12 December 2020

Different molecular forms of fibronectin in rheumatoid synovial fluid

1 reference

12 December 2020

The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin).

1 reference

12 December 2020

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage

1 reference

12 December 2020

New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

Chondrex: new marker of joint disease

1 reference

12 December 2020

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

1 reference

12 December 2020

Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins

1 reference

12 December 2020

Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent

1 reference

12 December 2020

Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases

1 reference

12 December 2020

Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA.

1 reference

12 December 2020

Toward imaging biomarkers for osteoarthritis

1 reference

12 December 2020

Use of biochemical markers to study and follow patients with osteoarthritis

1 reference

12 December 2020

MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays

1 reference

12 December 2020

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri

1 reference

12 December 2020

One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression

1 reference

12 December 2020

The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases

1 reference

12 December 2020

Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation

1 reference

12 December 2020

Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study

1 reference

12 December 2020

Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody

1 reference

12 December 2020

Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.

1 reference

12 December 2020

Post-translational processing of procollagens

1 reference

12 December 2020

Collagen type II C-telopeptide fragments as an index of cartilage degradation

1 reference

12 December 2020

The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.

1 reference

12 December 2020

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage

1 reference

12 December 2020

Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis

1 reference

12 December 2020

Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice

1 reference

12 December 2020

Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.

1 reference

12 December 2020

An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline

1 reference

12 December 2020

Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide

1 reference

12 December 2020

Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women

1 reference

12 December 2020

Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen

1 reference

12 December 2020

Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis

1 reference

12 December 2020

Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood

1 reference

12 December 2020

Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage

1 reference

12 December 2020

Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment

1 reference

12 December 2020

Molecular markers of processes in cartilage in joint disease.

1 reference

12 December 2020

A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression

1 reference

12 December 2020

10.1007/S11926-007-0017-Y

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17437662